ClinicalTrials.Veeva

Menu

The OSIRIS ECPR Trial

G

General University Hospital, Prague

Status

Not yet enrolling

Conditions

Extracorporeal Cardiopulmonary Resuscitation
Out-Of-Hospital Cardiac Arrest
Ventricular Fibrillation
Sudden Cardiac Arrest
Extracorporeal Membrane Oxygenation
Cardiac Arrest

Treatments

Procedure: Extracorporeal cardiopulmonary resuscitation based approach
Procedure: Conventional cardiopulmonary resuscitation

Study type

Interventional

Funder types

Other

Identifiers

NCT06805344
442024-41/24

Details and patient eligibility

About

The OSIRIS trial is an investigator-initiated, multicenter, multinational, open-label, randomized controlled trial with a 2:1 concealed allocation of refractory out-of-hospital cardiac arrest (OHCA) patients to the extracorporeal cardiopulmonary resuscitation (ECPR) based approach versus the conventional cardiopulmonary resuscitation (CCPR) approach.

Full description

ECPR for OHCA is a resource-intensive method and poses significant challenges for both prehospital and hospital systems. Recent meta-analyses have highlighted persisting uncertainties regarding the routine use of ECPR strategy for OHCA, emphasizing the need for further research.

The refractory OHCA trial is a multicenter, multinational, open-label, randomized trial with a 2:1 concealed allocation of refractory OHCA patients to ECPR-based approach versus CCPR approach.

ECPR-based approach is defined as advanced cardiac life support (ACLS) per current guidelines with aim to proceed to in-hospital or out-of-hospital veno-arterial extracorporeal membrane oxygenation (V-A ECMO) if (return of spontaneous circulation) ROSC is not achieved before the cannulation.

CCPR is defined as conventional ACLS per current guidelines without mechanical circulatory support (MCS) use until sustained ROSC is achieved or the patient pronounced dead.

This study was designed to test the hypothesis that invasive, ECPR-based approach when compared to CCPR:

  1. increases survival in selected adults with refractory OHCA.
  2. and can be successfully implemented in different cities and countries.

The study will include adults 18-70 years of age suffering refractory OHCA of presumed cardiac cause. Refractory OHCA is characterized as either 3 unsuccessful defibrillations in ongoing shockable rhythms or 10 minutes of ACLS without ROSC in the case of a non-shockable rhythm following the first or second defibrillation.

Enrollment

686 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age ≥18 and ≤ 70 years presumed or known
  2. Witnessed OHCA
  3. Bystander CPR provided
  4. Presumed cardiac or unknown cause
  5. An initial documented shockable rhythm of VF (ventricular fibrillation) or pulseless VT (ventricular tachycardia)
  6. Minimum of ≥ 10 min of ACLS without ROSC or at least ≥ 3 defibrillations in ongoing VF/pulseless VT
  7. Body morphology able to accommodate a mechanical chest compression device
  8. ECPR team and intensive care unit (ICU) capacity in the receiving center available
  9. Estimated transfer time from the scene to the hospital ≤ 30 minutes or to the scene ≤ 30 minutes
  10. Eligible for intensive care without restrictions or limitations

Exclusion criteria

  1. ACLS ≥ 30 minutes before randomization
  2. Known limitations in care or a Do Not Attempt to Resuscitate (DNAR) order
  3. Known severe disease making 90-day survival unlikely
  4. Known bleeding diathesis or acute or recent intracranial bleeding
  5. Known, obvious or suspected pregnancy
  6. Known pre-arrest severe cognitive dysfunction (mRS ≥ 4)
  7. Known hypothermia as a cause of cardiac arrest

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

686 participants in 2 patient groups

ECPR-based
Experimental group
Description:
ECPR-based approach is defined as advanced cardiac life support (ACLS) per current guidelines with aim to proceed to in-hospital or out-of-hospital veno-arterial extracorporeal membrane oxygenation (V-A ECMO) if return of spontaneous circulation (ROSC) is not achieved before the cannulation.
Treatment:
Procedure: Extracorporeal cardiopulmonary resuscitation based approach
CCPR
Active Comparator group
Description:
CCPR is defined as conventional advanced cardiac life support (ACLS) per current guidelines without mechanical circulatory support (MCS) use until sustained return of spontaneous circulation (ROSC) is achieved or the patient pronounced dead.
Treatment:
Procedure: Conventional cardiopulmonary resuscitation

Trial contacts and locations

0

Loading...

Central trial contact

Daniel Rob, MD, PhD; Jan Bělohlávek, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems